Health care-associated Staphylococcus aureus bloodstream infections: A clinical quality indicator for all hospitals

Medical Journal of Australia

Volumn 184, Issue 8, 2006, Pages 404-406

  Collignon, Peter J ^a,b   Wilkinson, Irene J ^c   Gilbert, Gwendolyn L ^d,e   Grayson, M Lindsay ^f,g   Whitby, R Michael ^h,i  

^a CANBERRA HOSPITAL   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c SA Health   (Australia)

^d Institute of Clinical Pathology and Medical Research NSW Health Pathology   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f AUSTIN HEALTH   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h PRINCESS ALEXANDRA HOSPITAL   (Australia)

ⁱ UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; METICILLIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; COMMUNICABLE DISEASE; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; HEALTH CARE; HEALTH CARE COST; HEALTH CARE FACILITY; HOSPITAL INFECTION; HUMAN; INCIDENCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; NONHUMAN; QUALITATIVE RESEARCH; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 33646260232     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2006.tb00291.x     Document Type: Article

References (21)

1. Waldvogel FA. Staphylococcus aureus (including staphylococcal toxic shock). In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. Philadelphia: Churchill Livingstone, 2000: 2069-2100.
2. Collignon P, Nimmo GR, Gottlieb T, Gosbell IB; Australian Group on Antimicrobial Resistance. Staphylococcus aureus bacteremia, Australia. Emerg Infect Dis 2005; 11: 554-561. Available at: http://www.cdc.gov/ncidod/EID/vol11no04/04-0772.htm (accessed Mar 2006).
3. Abramson MA, Sexton DJ. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteraemia: at what costs? Infect Control Hosp Epidemiol 1999; 20: 408-411.
4. Orsi G, Stefano L, Noah N. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs. Infect Control Hosp Epidemiol 2002; 23: 190-197.
5. Morin CA, Hadler JL. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis 2001; 184: 1029-1034.
6. Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36: 53-59.
7. Whitby M, McLaws ML, Berry G. Risk of death from methicillin resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 2001; 175: 264-267.
8. Staphylococcus aureus bacteraemia: England, Wales and Northern Ireland: January to December 2003. CDR Wkly 2004; 14: 1-5. Available at: http://www.hpa.org.uk/cdr/PDFfiles/2004/staph_ann_1604.pdf (accessed Mar 2006).
9. Staphylococcus aureus bacteraemia: England, Wales and Northern Ireland, January to December 2002. CDR Wkly 2003; 13: 5-10. Available at: http://www.hpa.org.uk/cdr/archives/2003/cdr1203.pdf (accessed Mar 2006).
10. European Antimicrobial Resistance Surveillance System (EARSS): susceptibility testing of invasive Staphylococcus aureus. Eurosurveillance [online publication] 2000; 5(3). Available at: http://www.eurosurveillance.org/em/v05n03/0503-225.asp (accessed Mar 2006).
11. Harbarth, S, Sax H, Gastmeier P. The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect 2003; 54: 258-266.
12. Haley RW. The scientific basis for using surveillance and risk factor data to reduce nosocomial infection rates. J Hosp Infect 1995; 30 Suppl: 3-14.
13. SA Department of Health. South Australian statewide nosocomial bloodstream infection report 2004. November 2005. Available at: http://www.health.sa.gov.au/infectioncontrol/ Default.aspx?PageContentID=18&tabid=147 (accessed Mar 2006).
14. Dreimanis D, Beckingham W, Collignon P, Roberts J. Staphylococcus aureus bacteraemia surveillance: a relatively easy to collect but accurate clinical indicator on serious health-care associated infections and antibiotic resistance. Aust Infect Control 2005; 10: 127-130.
15. Johnson PD, Martin R, Burrell LJ, et al. Efficacy of an alcohol/ chlorhexidine hand hygiene program in a hospital with high rates of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection. Med J Aust 2005; 183: 509-514.
16. Danish Staphylococcus aureus Bacteremia Group. Annual report on Staphylococcus aureus bacteremia in Denmark, 2002. Copenhagen: Statens Serum Institut, 2004. Available at: http://www.ssi.dk/graphics/dk/overvagning/Annual02.pdf (accessed Mar 2006).
17. Australian Infection Control Association and Safety + Quality Council. Blood stream infection (BSI) definition. Approved by the Healthcare Associated Infections Advisory Committee, September 2004. Available at: http://www.safetyandquality.org/bsidefinejun05.pdf (accessed Mar 2006).
18. Looke D, Pawsey M. "Signal infection" surveillance: when the data set is too small for statistical analysis. Aust Infect Control 2001; 6: 52-53.
19. Signal infection surveillance. Brisbane: Centre for Healthcare Related Infection Surveillance and Prevention, Queensland Health, 2004. Available at: http://www.chrispqld.com/documents/Section1-SISIntro.pdf (accessed Mar 2006).
20. Spiegelhalter DJ. Problems in assessing rates of infection with methicillin-resistant Staphylococcus aureus. BMJ 2005; 331: 1013-1015.
21. Duckworth G, Charlett A. Improving surveillance of MRSA bacteraemia. BMJ 2005; 331: 976-977.